Résumé
In order to evaluate the prognostic factors for progression and survival in patients with a low tumor mass asymptomatic multiple myeloma (MM), we studied 59 patients who had a long term follow-up. Cytogenetic abnormalities (using conventional cytogenetics) were observed in 14 out of 45 analyzable patients (31%). An abnormal karyotype and a bone marrow (BM) plasmacytosis > 15% were found to be adverse prognostic factors for progression in univariate and multivariate analysis.
langue originale | Anglais |
---|---|
Pages (de - à) | 2481-2484 |
Nombre de pages | 4 |
journal | Leukemia and Lymphoma |
Volume | 45 |
Numéro de publication | 12 |
Les DOIs | |
état | Publié - 1 déc. 2004 |
Modification externe | Oui |